Sohag University Faculty of Medicine
Sohag, Egypt
NCT Number: NCT07650513
Prediabetes is associated with impaired fasting glucose and/or impaired glucose tolerance. Recent data indicate that more than one-third of adults in affluent countries have prediabetes . Fasting glucose concentrations of 100-125 mg/dL, hemoglobin A1c (HbA1c) titers of 5.7-6.4%, and two-hour post-stimulus glucose levels of 140-199 mg/dL are used to identify prediabetes. Behavioral lifestyle changes and medications are useful in preventing the progression of prediabetes to T2DM .
Early detection and treatment of T2DM and prediabetes can prevent future health problems. However, many people with metabolic disorders are undiagnosed, partly due to the clinical practices and knowledge of primary care physicians (PCPs). PCPs play a critical role in diabetes prevention through the detection and management of prediabetes. Successful screening initiatives and the start of appropriate management interventions depend on PCPs' level of prediabetes knowledge Most patients with prediabetes do not receive evidence-based preventive care from their PCPs . Systemic barriers hinder physicians' ability to provide the best evidence-based practice, such as performance measures, insurance reimbursement, cultural expectations, and a lack of tools and staffing resources
This study is active but is not currently recruiting participants.
Notify Me25 year and older
All sexes
Observational
Sohag, Egypt
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 - Physicians who decline to provide informed consent.
2-Physicians who do not complete at least 90% of the questionnaire items.
3-Physicians not actively practicing at a Sohag government hospital or clinic during the study period.
Time frame: Single time point during data collection period (April 1, 2026 to June 30, 2026)
Proportion of physicians who correctly identify: (1) risk factors for diabetes screening (e.g., age ≥35, BMI ≥25 kg/m², hypertension, family history of diabetes), (2) fasting glucose diagnostic cut-offs for prediabetes (100-125 mg/dL) and diabetes (≥126 mg/dL), (3) HbA1c cut-offs for prediabetes (5.7-6.4%) and diabetes (≥6.5%), (4) lifestyle modification recommendations for prediabetes (minimum 7% weight loss and 150 minutes of physical activity per week), and (5) appropriate use of metformin for prediabetes prevention.Validated structured self-administered questionnaire (adapted from Tseng et al., 2019) distributed via Google Forms, including multiple-choice and true/false questions
Sohag University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04168372
Glucose Intolerance, Glucose Metabolism Disorders
Vallejo, California, United States
View Trial DetailsNCT06053177
Apnea, Cardiovascular Diseases
Liverpool, United Kingdom
View Trial DetailsNCT06387797
At Risk for Type 2 Diabetes Mellitus, Glucose Intolerance
Las Vegas, Nevada, United States
View Trial DetailsNCT07271940
Body Weight, Diabetes Mellitus
Madison, Wisconsin, United States
View Trial Details